Jul 15, 2012
New findings published today in the journal Science Translational Medicine show that host genetics played a role in protection against HIV infection in the landmark RV144 vaccine trial conducted in Thailand.
Apr 5, 2012
Follow-up Studies to the RV144 HIV Vaccine Trial Provide Possible Explanation for How the Vaccine May Have Protected Against HIV
Jan 24, 2012
Promising Results of Novel Combination HIV Vaccine. Preclinical Study of HIV Vaccine Candidates Provides Strong Rationale for Clinical Trials
Sep 13, 2011
Follow-up Study to RV144 HIV Vaccine Trial Shows No Effect on Disease Progression in Infected Volunteers
Sep 28, 2010
A Phase I study, RV262, recently began to evaluate a combination DNA prime/MVA vector boost vaccine regimen that was developed to protect against diverse subtypes of HIV.
Oct 20, 2009
Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conference Provide Insight for Future Research